Asan Multivessel Registry

Conditions

Coronary Artery Disease

Keywords

Multivessel

Brief summary

The purpose of this study is to evaluate long-term prognoses of patients with multivessel coronary disease treated medically or surgically or percutaneously in real world practice.

Park J, Kim SH, Kim M, Lee J, Choi Y, Kim H, Kim TO, Kang DY, Ahn JM, Yoo JS, Kim HJ, Kim JB, Choo SJ, Chung CH, Park SJ, Park DW, Asan-Multivessel Registry Investigators.

2023-07-211 citations

10.1016/j.amjcard.2023.06.083

Prognostic Impact of Mildly Impaired Renal Function in Patients Undergoing Multivessel Coronary Revascularization.

Kim TO, Kang DY, Ahn JM, Kim SO, Lee PH, Lee J, Kim JH, Kim HJ, Kim JB, Choo SJ, Chung CH, Lee JW, Park SJ, Park DW, Asan Medical Center–Multivessel Revascularization Registry Investigators.

2022-04-0110 citations

10.1016/j.jacc.2022.01.035

Interventions

OTHERTreatment

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

No

Inclusion criteria

* Patients with multivessel disease from 1995 in Asan Medical Center * Age 19 and more

Exclusion criteria

* For prospective cohort, not agreeing to participate with written informed consent form

Design outcomes

Primary

Measure	Time frame	Description
composite event	1year	death, myocardial infarction, stroke, revascularization

Secondary

Measure	Time frame	Description
Re-hospitalization	1year	—
Stent thrombosis	1year	by ARC(Academic Research Consortium) category
Revascularization	1year	—
Bleeding	1year	—
Death	1year	—
Myocardial Infarction	1year	—
Stroke	1year	—
Angina symptom	1year	—

Countries

South Korea

Outcome results

None listed